Increased FFA levels due to lipid metabolic disorders are known to induce inflammation associated with insulin resistance and T2DM mechanism, reducing glucose uptake, increasing hepatic glucose production, impairing insulin signaling pathways, and causing adipokine secretion disorders [16,53]. The gene discussed is INS; the disease is Disorder of lipid metabolism.